Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
02 Mar 2021
Historique:
pubmed: 11 3 2021
medline: 11 3 2021
entrez: 10 3 2021
Statut: epublish

Résumé

Adjuvanted soluble protein vaccines have been used extensively in humans for protection against various viral infections based on their robust induction of antibody responses. Here, soluble prefusion-stabilized spike trimers (preS dTM) from the severe acute respiratory syndrome coronavirus (SARS-CoV-2) were formulated with the adjuvant AS03 and administered twice to nonhuman primates (NHP). Binding and functional neutralization assays and systems serology revealed that NHP developed AS03-dependent multi-functional humoral responses that targeted multiple spike domains and bound to a variety of antibody F

Identifiants

pubmed: 33688652
doi: 10.1101/2021.03.02.433390
pmc: PMC7941623
pii:
doi:

Types de publication

Preprint

Langues

eng

Déclaration de conflit d'intérêts

Declaration of interests All authors have declared the following interests: VL, TB, CB, SR, TMF, DC, RC are Sanofi Pasteur employees and may hold stock. MK, RvdM, and CG are employees of the GSK group of companies and report ownership of GSK shares.

Références

Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Vaccine. 2020 Nov 25;38(50):7892-7896
pubmed: 33139139
PLoS Negl Trop Dis. 2018 Oct 24;12(10):e0006862
pubmed: 30356267
NPJ Vaccines. 2016;1:
pubmed: 29250436
Vaccine. 2009 Oct 23;27(45):6284-90
pubmed: 19856521
N Engl J Med. 1968 Oct 24;279(17):893-900
pubmed: 20617594
J Clin Microbiol. 1988 Aug;26(8):1595-7
pubmed: 2459154
NPJ Vaccines. 2019 Dec 20;4:54
pubmed: 31885877
N Engl J Med. 2016 Sep 15;375(11):1019-32
pubmed: 27626517
Curr Protoc Immunol. 2020 Dec;131(1):e116
pubmed: 33215858
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Sci Transl Med. 2020 Nov 4;12(568):
pubmed: 33077678
Structure. 1997 Jun 15;5(6):789-98
pubmed: 9261070
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357
pubmed: 28807998
J Infect Dis. 1988 Jul;158(1):160-5
pubmed: 2839578
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
J Immunol Methods. 2016 Dec;439:74-78
pubmed: 27594593
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17957-17964
pubmed: 32661157
Science. 2020 Aug 7;369(6504):650-655
pubmed: 32571838
Front Immunol. 2020 Sep 11;11:526965
pubmed: 33013922
Nat Med. 2009 Jan;15(1):34-41
pubmed: 19079256
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
Clin Vaccine Immunol. 2012 Feb;19(2):209-18
pubmed: 22190392
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
J Virol. 2006 Oct;80(19):9896-8
pubmed: 16973594
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
Lancet. 2007 Aug 18;370(9587):580-9
pubmed: 17707753
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Nat Commun. 2015 Jul 28;6:7712
pubmed: 26218507
Clin Vaccine Immunol. 2015 Nov 11;23(1):73-7
pubmed: 26561390
J Pediatr. 1992 May;120(5):686-9
pubmed: 1315853
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288662
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):125-30
pubmed: 24344259
J Immunol Methods. 2011 Mar 7;366(1-2):8-19
pubmed: 21192942
J Infect Dis. 2016 Dec 1;214(11):1717-1727
pubmed: 27609809
Front Immunol. 2015 Apr 29;6:207
pubmed: 25972874
Clin Exp Immunol. 2002 Dec;130(3):386-92
pubmed: 12452827
Lancet. 2021 Feb 20;397(10275):682-694
pubmed: 33524311
Nature. 2021 Feb;590(7847):630-634
pubmed: 33276369
Lancet. 2020 Sep 26;396(10255):887-897
pubmed: 32896291
NPJ Vaccines. 2018 Oct 1;3:40
pubmed: 30302282
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
J Clin Immunol. 2011 Jun;31(3):443-54
pubmed: 21174144
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
Int Immunol. 2013 Mar;25(3):183-95
pubmed: 23143476
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11157-11162
pubmed: 29073020
J Immunol. 1998 Jun 1;160(11):5280-7
pubmed: 9605125
Cell Host Microbe. 2020 May 13;27(5):841-848.e3
pubmed: 32289263
N Engl J Med. 2020 Dec 10;383(24):2320-2332
pubmed: 32877576
J Virol. 2002 Nov;76(22):11561-9
pubmed: 12388717
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Vaccine. 2010 Jan 8;28(3):849-57
pubmed: 19835828
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
Nature. 2020 Aug;584(7821):443-449
pubmed: 32668443
J Immunol Methods. 2019 Aug;471:46-56
pubmed: 31132351
Nat Commun. 2020 Aug 27;11(1):4303
pubmed: 32855401
PLoS One. 2012;7(4):e35421
pubmed: 22536382
Cell. 2016 Oct 6;167(2):433-443.e14
pubmed: 27667685
J Clin Microbiol. 1986 Aug;24(2):197-202
pubmed: 3755730
Lancet Infect Dis. 2021 Feb;21(2):181-192
pubmed: 33217362
Cell Rep. 2020 Oct 27;33(4):108322
pubmed: 33091382
Science. 2004 Mar 5;303(5663):1529-31
pubmed: 14976261
Expert Rev Vaccines. 2012 Mar;11(3):349-66
pubmed: 22380826
Immunity. 2010 Oct 29;33(4):492-503
pubmed: 21029960
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
J Immunol Methods. 2012 Dec 14;386(1-2):117-23
pubmed: 23023091
Vaccine. 2019 May 21;37(23):3006-3021
pubmed: 31031030
J Hepatol. 2009 Apr;50(4):805-16
pubmed: 19231008
Lancet Infect Dis. 2016 Oct;16(10):1154-1168
pubmed: 27373900
Cytometry A. 2019 Mar;95(3):261-263
pubmed: 30681265
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
J Immunol Methods. 2019 Oct;473:112630
pubmed: 31301278
Clin Immunol. 2016 Aug;169:16-27
pubmed: 27236001
Am J Epidemiol. 1969 Apr;89(4):449-63
pubmed: 4305200
Clin Vaccine Immunol. 2012 Jan;19(1):79-83
pubmed: 22072721
J Virol. 2003 Aug;77(16):8801-11
pubmed: 12885899
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Sci Rep. 2018 Oct 24;8(1):15701
pubmed: 30356097
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
J Immunol. 1989 Jul 15;143(2):518-25
pubmed: 2472442
J Pediatr. 2018 Feb;193:84
pubmed: 29389454
J Immunol. 1993 Aug 15;151(4):2032-40
pubmed: 8345194

Auteurs

Joseph R Francica (JR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Barbara J Flynn (BJ)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Kathryn E Foulds (KE)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Amy T Noe (AT)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Anne P Werner (AP)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Ian N Moore (IN)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Matthew Gagne (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Timothy S Johnston (TS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Courtney Tucker (C)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Rachel L Davis (RL)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Britta Flach (B)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Sarah O'Connell (S)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Shayne F Andrew (SF)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Evan Lamb (E)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Dillon R Flebbe (DR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Saule T Nurmukhambetova (ST)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Mitzi M Donaldson (MM)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

John-Paul M Todd (JM)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Alex Lee Zhu (AL)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
PhD program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.

Caroline Atyeo (C)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
PhD program in Virology, Division of Medical Sciences, Harvard University, Boston, MA, USA.

Stephanie Fischinger (S)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
PhD program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.

Matthew J Gorman (MJ)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.

Sally Shin (S)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.

Venkata Viswanadh Edara (VV)

Centers for Childhood Infections and Vaccines; Children's Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, 30329, USA.
Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.
Yerkes National Primate Research Center, Atlanta, GA 30329, USA.

Katharine Floyd (K)

Centers for Childhood Infections and Vaccines; Children's Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, 30329, USA.
Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.
Yerkes National Primate Research Center, Atlanta, GA 30329, USA.

Lilin Lai (L)

Centers for Childhood Infections and Vaccines; Children's Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, 30329, USA.
Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.
Yerkes National Primate Research Center, Atlanta, GA 30329, USA.

Alida Tylor (A)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Elizabeth McCarthy (E)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Valerie Lecouturier (V)

Sanofi Pasteur, Marcy l'Etoile, France.

Sophie Ruiz (S)

Sanofi Pasteur, Marcy l'Etoile, France.

Catherine Berry (C)

Sanofi Pasteur, Marcy l'Etoile, France.

Timothy Tibbitts (T)

Sanofi Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.

Hanne Andersen (H)

Bioqual, Inc., Rockville, MD, USA.

Anthony Cook (A)

Bioqual, Inc., Rockville, MD, USA.

Alan Dodson (A)

Bioqual, Inc., Rockville, MD, USA.

Laurent Pessaint (L)

Bioqual, Inc., Rockville, MD, USA.

Alex Van Ry (AV)

Bioqual, Inc., Rockville, MD, USA.

Marguerite Koutsoukos (M)

GSK, Wavre, Belgium.

Cindy Gutzeit (C)

GSK, Rixensart, Belgium.

I-Ting Teng (IT)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Tongqing Zhou (T)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Dapeng Li (D)

Duke Human Vaccine Institute, Duke University, Durham, NC 27708, USA.

Barton F Haynes (BF)

Duke Human Vaccine Institute, Duke University, Durham, NC 27708, USA.

Peter D Kwong (PD)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Adrian McDermott (A)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Mark G Lewis (MG)

Bioqual, Inc., Rockville, MD, USA.

Tong Ming Fu (TM)

Sanofi Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.

Roman Chicz (R)

Sanofi Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.

Robbert van der Most (R)

GSK, Rixensart, Belgium.

Kizzmekia S Corbett (KS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Mehul S Suthar (MS)

Centers for Childhood Infections and Vaccines; Children's Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, 30329, USA.
Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.
Yerkes National Primate Research Center, Atlanta, GA 30329, USA.

Galit Alter (G)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.

Mario Roederer (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Nancy J Sullivan (NJ)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Daniel C Douek (DC)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Barney S Graham (BS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Danilo Casimiro (D)

Sanofi Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.

Robert A Seder (RA)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Classifications MeSH